SCHEMBL30587153

SCHEMBL30587153

O=C(Nc1ccc(-c2nnc(-c3ccccc3)o2)cc1)c1ccnc(Cl)c1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 5/20 0.64
NPC1 O15118 5/20 0.64
RAB9A P51151 5/20 0.64
ALDH1A1 P00352 4/20 0.64
HPGD P15428 3/20 0.64
SMN1; SMN2 Q16637 2/20 0.64
SMO Q99835 1/20 0.61
HSD17B10 Q99714 3/20 0.54
MAPK1 P28482 3/20 0.54
USP2 O75604 1/20 0.54
MEN1 O00255 2/20 0.52
KMT2A Q03164 2/20 0.52
TP53 P04637 1/20 0.52
POLB P06746 1/20 0.52
LCLAT1 Q6UWP7 2/20 0.52
ALOX15 P16050 2/20 0.52
NPSR1 Q6W5P4 3/20 0.52
KDM4E B2RXH2 4/20 0.51
CYP3A4 P08684 2/20 0.51
MAPT P10636 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24473977 1.00 TSHR (0.64) TSHRNPC1RAB9AALDH1A1HPGD
SCHEMBL26078553 0.86 ALDH1A1 (0.64) TSHRNPC1RAB9AALDH1A1HPGD
SCHEMBL736261 0.83 LMNA (0.62) NPC1RAB9AALDH1A1HPGDSMN1; SMN2
SCHEMBL30587152 0.83 ALDH1A1 (0.60) TSHRNPC1RAB9AALDH1A1HPGD
SCHEMBL24473982 0.83 ALDH1A1 (0.60) TSHRNPC1RAB9AALDH1A1HPGD
SCHEMBL24474001 0.82 SMN1; SMN2 (0.67) TSHRNPC1RAB9AALDH1A1HPGD
SCHEMBL24474019 0.81 KDM4E (0.74) TSHRNPC1RAB9AALDH1A1HPGD
SCHEMBL8770855 0.80 NPC1 (0.74) TSHRNPC1RAB9AALDH1A1HPGD
SCHEMBL24473983 0.79 NPC1 (0.61) TSHRNPC1RAB9AALDH1A1HPGD
SCHEMBL30587155 0.79 NPC1 (0.61) TSHRNPC1RAB9AALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116457353-A N-substituted 4- (5-phenyl-1, 3, 4-oxadiazol-2-yl) anilines for the treatment and prophylaxis of hepatitis b virus infections 豪夫迈·罗氏有限公司 2023-07-18 CN claimed
CN-116457353-A N-substituted 4- (5-phenyl-1, 3, 4-oxadiazol-2-yl) anilines for the treatment and prophylaxis of hepatitis b virus infections 豪夫迈·罗氏有限公司 2023-07-18 CN disclosed